| scholarly article | Q13442814 |
| P50 | author | Paolo Onori | Q38326143 |
| Adolfo Francesco Attili | Q42889215 | ||
| Vincenzo Cardinale | Q43246333 | ||
| Domenico Alvaro | Q54325183 | ||
| Mario Angelico | Q56530094 | ||
| Antonio Franchitto | Q58705774 | ||
| P2093 | author name string | Eugenio Gaudio | |
| Mario Strazzabosco | |||
| Gianfranco Alpini | |||
| Alessia Torrice | |||
| Douglas M Jefferson | |||
| Maria Grazia Mancino | |||
| Fabrizio Stefanelli | |||
| P2860 | cites work | Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway | Q22253479 |
| Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells | Q28505110 | ||
| The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis | Q28568468 | ||
| Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases | Q28576110 | ||
| Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling | Q28579739 | ||
| Molecular genetics and mechanism of autosomal dominant polycystic kidney disease | Q33828298 | ||
| Autosomal dominant polycystic kidney disease: molecular genetics and molecular pathogenesis. | Q33921274 | ||
| Regulation and deregulation of cholangiocyte proliferation | Q34010481 | ||
| Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease | Q34131943 | ||
| Intraflagellar transport and cilia-dependent diseases. | Q34166357 | ||
| Regulation of cholangiocyte proliferation | Q34229378 | ||
| Alfa and beta estrogen receptors and the biliary tree | Q34772517 | ||
| Functional heterogeneity of cholangiocytes | Q34932773 | ||
| Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle | Q35071856 | ||
| Cystic disease in women: clinical characteristics and medical management | Q35077660 | ||
| Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma | Q35222052 | ||
| Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor | Q35551142 | ||
| Polycystins, calcium signaling, and human diseases. | Q35874353 | ||
| A physiological view of the primary cilium | Q36041059 | ||
| Polycystins: polymodal receptor/ion-channel cellular sensors | Q36124622 | ||
| New advances in evaluation and management of patients with polycystic liver disease | Q36310072 | ||
| Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver | Q36714754 | ||
| Hepatic cysts in autosomal dominant polycystic kidney disease | Q37943720 | ||
| The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro | Q40194824 | ||
| The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells | Q40900283 | ||
| Autosomal dominant polycystic kidney disease decreases anion exchanger activity | Q41112878 | ||
| Primary cilia in normal and pathological tissues | Q41160293 | ||
| The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis | Q41223700 | ||
| Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium | Q41304931 | ||
| Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease | Q42546669 | ||
| Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. | Q44054049 | ||
| Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. | Q44080024 | ||
| Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin | Q44808980 | ||
| Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. | Q45104132 | ||
| Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3. | Q51812633 | ||
| Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. | Q52171297 | ||
| Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. | Q52552433 | ||
| Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. | Q53563592 | ||
| Scanning electron microscopy demonstration of cilia in rat intrahepatic bile ducts. | Q54606541 | ||
| Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. | Q55065536 | ||
| Activation of the IGF1 System Characterizes Cholangiocyte Survival During Progression of Primary Biliary Cirrhosis | Q57791888 | ||
| Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro | Q67866726 | ||
| Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease | Q68842349 | ||
| Insulin-like growth factor I in human gastrointestinal exocrine secretions | Q72440609 | ||
| Autosomal dominant polycystic kidney disease | Q72805647 | ||
| Polycystic kidney disease--the ciliary connection | Q73087592 | ||
| Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats | Q73288692 | ||
| Isolation and characterization of cholangiocyte primary cilia | Q80088123 | ||
| Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid | Q80594500 | ||
| Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis | Q81258801 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autosomal dominant polycystic kidney disease | Q15443105 |
| autosomal dominant polycystic kidney | Q2732398 | ||
| P304 | page(s) | 321-332 | |
| P577 | publication date | 2008-01-17 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease | |
| P478 | volume | 172 |
| Q39186912 | An update on the pathophysiology and management of polycystic liver disease |
| Q24656249 | Autosomal dominant polycystic kidney disease: the last 3 years |
| Q37317821 | Cholangiociliopathies: genetics, molecular mechanisms and potential therapies |
| Q48090042 | Close pathological correlations between chronic kidney disease and reproductive organ-associated abnormalities in female cotton rats |
| Q37327417 | Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging. |
| Q42213282 | Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib |
| Q38072284 | Diagnosis and management of polycystic liver disease |
| Q52587753 | Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease. |
| Q34399971 | ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice |
| Q43204321 | Estrogen stimulates female biliary epithelial cell interleukin-6 expression in mice and humans |
| Q46245959 | Expression and localization of growth hormone receptor in the oviduct of cyclic and pregnant pigs and mid-implantation conceptuses |
| Q37584658 | Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases. |
| Q34500619 | Food Restriction Ameliorates the Development of Polycystic Kidney Disease |
| Q28572123 | HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis |
| Q35185224 | Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases |
| Q33723830 | Isolated polycystic liver disease |
| Q52589204 | Liver Failure in Advanced Adult-onset Polycystic Kidney Disease. |
| Q47706205 | Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling |
| Q34091331 | Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. |
| Q33816594 | Novel targets for the treatment of autosomal dominant polycystic kidney disease |
| Q36739229 | Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. |
| Q40025433 | Pleuritic chest pain from portal hypertensive gastropathy in ESRD patient with autosomal dominant polycystic kidney disease misdiagnosed as pericarditis |
| Q33648233 | Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management |
| Q33949172 | Polycystic liver diseases. |
| Q27001174 | Polycystic liver diseases: advanced insights into the molecular mechanisms |
| Q34358007 | Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology |
| Q33783730 | Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. |
| Q34992322 | Role of sex hormones in the modulation of cholangiocyte function. |
| Q95942116 | Roles of trained immunity in the pathogenesis of cholangiopathies: a novel therapeutic target |
| Q37905881 | Systematic review: the pathophysiology and management of polycystic liver disease |
| Q37157705 | Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. |
| Q26852534 | The Liver and Polycystic Kidney Disease |
| Q39381392 | The cholangiocyte primary cilium in health and disease. |
| Q38443908 | Therapeutic Targets in Polycystic Liver Disease |
| Q38737946 | Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease |
Search more.